论文部分内容阅读
目的探讨比较不同治疗方案在分泌性中耳炎中的疗效。方法选取2009年2月～2010年于本院进行治疗的60例(66耳)患者为研究对象,将其随机分为A组(氨溴索组)30例(33耳)和B组(地塞米松联合糜蛋白酶组)30例(33耳),后将两组患者的治疗总有效率、不良反应发生率及治疗前、治疗后1周、4周及8周的气导平均听阈进行统计及比较。结果 A组治疗总有效率高于B组,不良反应发生率低于B组,治疗后1周、4周及8周的气导平均听阈优于B组,P均<0.05,均有显著性差异。结论氨溴索在分泌性中耳炎中的疗效优于地塞米松联合糜蛋白酶,值得推广应用。
Objective To compare the curative effects of different treatment regimens in secretory otitis media. Methods Sixty patients (66 ears) who were treated in our hospital from February 2009 to 2010 were randomly divided into three groups: A group (ambroxol group), 30 cases (33 ears) and group B Thirty patients (33 ears) were treated with dexamethasone and chymotrypsin. The total effective rate of the two groups of patients, the incidence of adverse reactions and the mean value of the mean airway conductance before treatment, 1 week, 4 weeks and 8 weeks after treatment And compare. Results The total effective rate of treatment in group A was higher than that in group B, and the incidence of adverse reactions was lower than that in group B. The mean value of air conduction at 1 week, 4 weeks and 8 weeks after treatment was better than that in group B (P <0.05) difference. Conclusions Ambroxol is superior to dexamethasone and chymotrypsin in the treatment of secretory otitis media, which is worth popularizing.